8-KEarnings & ResultsOther EventsExhibits & Filings

REGENERON PHARMACEUTICALS, INC. 8-K Report, Financial Results (Aug 4, 2015)

Filed August 4, 2015For Securities:REGN

Summary

Regeneron Pharmaceuticals, Inc. (REGN) filed an 8-K on August 4, 2015, primarily to report its financial and operating results for the second quarter ended June 30, 2015. The press release containing these results, dated August 4, 2015, is furnished as an exhibit. Investors should note that this information is being furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, unless specifically incorporated into a future filing. Additionally, Regeneron announced its intention to utilize its corporate website and Twitter feed for disseminating important company information, including material to investors. This expanded communication strategy supplements traditional channels like SEC filings, press releases, and conference calls, prompting investors to actively monitor these platforms for updates.

Key Highlights

  • 1Regeneron announced its second quarter 2015 financial and operating results via a press release dated August 4, 2015.
  • 2The press release is furnished as Exhibit 99.1 to the 8-K filing.
  • 3Financial and operating results for the quarter ended June 30, 2015, are disclosed.
  • 4Information furnished in this Item 2.02 is not considered "filed" for Section 18 of the Exchange Act purposes unless expressly incorporated.
  • 5Regeneron will use its website and Twitter feed to publish important company information, including material for investors.
  • 6Investors are encouraged to monitor these social media channels in addition to traditional SEC filings and press releases.

Frequently Asked Questions

The primary purpose of this 8-K filing is to announce and provide access to Regeneron's financial and operating results for the second quarter ended June 30, 2015, through an accompanying press release.

The press release is being "furnished" and not "filed" under Section 18 of the Securities Exchange Act of 1934. This means the information within it, unless specifically referenced in another filing, does not carry the same legal implications as information that is officially filed with the SEC.

Regeneron is expanding its communication strategy to include its official website and Twitter feed for disseminating important company information, including potentially material information for investors.

Regeneron encourages investors, media, and other interested parties to actively review information published on its website and Twitter feed, in addition to its regular SEC filings, press releases, conference calls, and webcasts.